Having spent 25 years at Stanford Medicine, and having developed and invested in numerous health-tech ventures and technologies, I embrace the Cor investment opportunity as a truly game changing and ground floor opportunity. Cor and its powerful spectrometer technology provides an abundant of applications worldwide useage, especially in guiding population health trends and personal wellness managment measuring an indvidual's personal responce to diet, nutritional suppliments and exercise. Today, as one would appreciate, when one takes and analyzes blood, they do so to diagnose a disease condition. You can say today that blood testing drives medical visits and treatments. However, in the spirit of “think different” (as Steve Jobs would suggest!), it would be very powerful to have the ability to have our blood analyzed conveniently and frequently enough so that it informs and trigger processes to guide an individual’s and family’s health, longevity, and wellbeing behavior? Moreover, Cor seems to have designed a system that delivers an incredible wellness and wellbeing platform at a very reasonable consumer price point. I am BULLISH on COR. They have a great team, strong founding investors, and growing list of strategic partners that, I am sure will change the game of individual and public wellness and wellbeing.